To note, a higher MMP-9 serum level has been reported in NAFLD patients compared to control patients but it did not allow distinguishing NAFL patients from NASH patients due to the small sample size and because the authors have not studied patient subgroups76. Here, MMP9 is linked to metabolic dysfunction-associated steatohepatitis.